How an AI solution can design new tuberculosis drug regimens

With a shortage of new tuberculosis drugs in the pipeline, a software tool can predict how current drugs–including unlikely candidates — can be combined in new ways to create more effective treatments.

Leave a Reply

Your email address will not be published. Required fields are marked *